Work

Abstract 3990: Real-world evidence of KMT2C mutation as a biomarker of sensitivity to platinum-based therapy in solid cancers

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-3990

Authors: Bruno Bockorny, Yingying Yu, Pedro Danielian, Yujing Jan Heng, Xiaohui Li, Stamatina Fragkogianni, Lisa Macera, Metamia Ciampricotti, Gerburg M. Wulf

Institution: Beth Israel Deaconess Medical Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148814070

Cites:

Cited by:

Related to: